|
374
|
1165
|
4jt6A |
Structure of mtordeltan-mlst8-pi-103 complex |
|
93
|
405
|
4pl3A |
Crystal structure of murine ire1 in complex with mkc9989 inhibitor |
|
0
|
27
|
4p7iC |
Crystal structure of the merlin ferm/dcaf1 complex |
|
86
|
310
|
4pxwA |
Crystal structure of human dcaf1 wd40 repeats (q1250l) |
|
107
|
403
|
4pl5A |
Crystal structure of murine ire1 in complex with oicr573 inhibitor |
|
84
|
293
|
4p90A |
Crystal structure of the kinase domain of human pak1 in complex with compound 15 |
|
19
|
89
|
4qegA |
Crystal structure of domain i10 from titin (space group p41) |
|
133
|
438
|
4pu5A |
Shewanella oneidensis toxin antitoxin system toxin protein hipa bound with amppnp and mg |
|
66
|
271
|
4q2aA |
Wnk1: a chloride sensor via autophosphorylation |
|
103
|
347
|
4pteA |
Structure of a carvoxamide compound (15) (n-[4-(isoquinolin-7-yl)pyridin-2-yl]cyclopropanecarboxamide) to gsk3b |
|
326
|
1052
|
4l23A |
Crystal structure of p110alpha complexed with nish2 of p85alpha and pi-103 |
|
86
|
281
|
4ow8A |
Crystal structure of kinase domain of pkna from mtb |
|
379
|
1165
|
4jt5A |
Mtordeltan-mlst8-pp242 complex |
|
77
|
264
|
4prjA |
Aurora a kinase domain with compound 2 (n-[1-(3-cyanobenzyl)-1h-pyrazol-4-yl]-6-(1h-pyrazol-4-yl)-1h-indazole-3-carboxamide) |
|
99
|
347
|
4ptgA |
Structure of a carboxamine compound (26) (2-{2-[(cyclopropylcarbonyl)amino]pyridin-4-yl}-4-methoxypyrimidine-5-carboxamide) to gsk3b |
|
89
|
346
|
4ptcA |
Structure of a carboxamide compound (3) (2-{2-[(cyclopropylcarbonyl)amino]pyridin-4-yl}-4-oxo-4h-1lambda~4~,3-thiazole-5-carboxamide) to gsk3b |
|
84
|
278
|
4pf4A |
1.1a x-ray structure of the apo catalytic domain of death-associated protein kinase 1, aa 1-277 |
|
33
|
123
|
4otmA |
Crystal structure of the c-terminal domain from yeast gcn2 |
|
70
|
274
|
4pwnA |
Crystal structure of active wnk1 kinase |
|
110
|
402
|
4pl4A |
Crystal structure of murine ire1 in complex with oicr464 inhibitor |
|
77
|
262
|
4p1nA |
Crystal structure of atg1-atg13 complex |
|
63
|
309
|
4q5jA |
Crystal structure of semet derivative bri1 in complex with bki1 |
|
104
|
360
|
4nm7A |
Crystal structure of gsk-3/axin complex bound to phosphorylated wnt receptor lrp6 e-motif |
|
88
|
291
|
4njdA |
Structure of p21-activated kinase 4 with a novel inhibitor ky-04031 |
|
18
|
43
|
4oh8A |
Crystal structure of the human mst1-rassf5 sarah heterodimer |
|
89
|
308
|
4neuA |
X-ray structure of receptor interacting protein 1 (rip1)kinase domain with a 1-aminoisoquinoline inhibitor |
|
143
|
494
|
4o0mA |
Crystal structure of t. elongatus bp-1 clock protein kaic |
|
72
|
266
|
4o0sA |
Crystal structures of human kinase aurora a |
|
73
|
282
|
4nzwB |
Crystal structure of stk25-mo25 complex |
|
30
|
109
|
4nxbA |
Crystal structure of ilov-i486(2lt) at ph 7.0 |
|
102
|
359
|
4nm0A |
Crystal structure of peptide inhibitor-free gsk-3/axin complex |
|
46
|
212
|
4nkbA |
Crystal structure of the cryptic polo box (cpb)of zyg-1 |
|
84
|
296
|
4obqA |
Map4k4 in complex with inhibitor (compound 31), n-[3-(4-aminoquinazolin-6-yl)-5-fluorophenyl]-2-(pyrrolidin-1-yl)acetamide |
|
78
|
274
|
4n6yA |
Pim1 complexed with a phenylcarboxamide |
|
96
|
291
|
4o0yA |
Back pocket flexibility provides group-ii pak selectivity for type 1 kinase inhibitors |
|
72
|
266
|
4o0uA |
Crystal structures of human kinase aurora a |
|
87
|
307
|
4nusA |
Rsk2 n-terminal kinase in complex with ljh685 |
|
100
|
293
|
4nfnA |
Human tau tubulin kinase 1 (ttbk1) complexed with 3-({5-[(4-amino-4-methylpiperidin-1-yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl}amino)-5-bromophenol |
|
71
|
310
|
4o38A |
Crystal structure of the human cyclin g associated kinase (gak) |
|
70
|
281
|
4o27B |
Crystal structure of mst3-mo25 complex with wif motif |
|
88
|
291
|
4o0vA |
Back pocket flexibility provides group-ii pak selectivity for type 1 kinase inhibitors |
|
96
|
309
|
4nw5A |
Rsk2 n-terminal kinase in complex with 2-amino-7-substituted benzoxazole compound 8 |
|
19
|
51
|
4nr2A |
Crystal structure of stk4 (mst1) sarah domain |
|
98
|
316
|
4nifA |
Heterodimeric structure of erk2 and rsk1 |
|
92
|
293
|
4nfmA |
Human tau tubulin kinase 1 (ttbk1) |
|
81
|
295
|
4oboA |
Map4k4 in complex with inhibitor (compound 22), 6-(3-chlorophenyl)quinazolin-4-amine |
|
319
|
1051
|
4l1bA |
Crystal structure of p110alpha complexed with nish2 of p85alpha |
|
74
|
267
|
4o0wA |
Crystal structures of human kinase aurora a |
|
32
|
106
|
4nxfA |
Crystal structure of ilov-i486(2lt) at ph 8.0 |
|
106
|
378
|
4nu1A |
Crystal structure of a transition state mimic of the gsk-3/axin complex bound to phosphorylated n-terminal auto-inhibitory ps9 peptide |
